A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- Jichi Medical University
- Enrollment
- 1462
- Locations
- 1
- Primary Endpoint
- Distribution rate based on the home BP of the patients.
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice.
Therefore, we conduct Asia BP@Home study to assess HBP control status in each Asian country and develop an Asian consensus and Asia-specific treatment for hypertension.
Detailed Description
Blood pressure variability (BPV) is being increasingly recognized as an important influence on hypertension outcomes as well as a risk factor for other cardiovascular (CV) events. However, in Asia there is a current lack of awareness of BPV and its significance on patient outcomes. Furthermore, there is ongoing debate on the role of home blood pressure (HBP) monitoring in managing hypertension patients and uncertainty on how best to integrate it into clinical practice. The main purpose of this study is to: * Assess HBP control status in each Asian country * Develop an Asian consensus and Asia-specific treatment for hypertension * Improve the management of hypertension in Asia by encouraging patients to monitor HBP
Investigators
Kazuomi Kario
Professor & Chairman
Jichi Medical University
Eligibility Criteria
Inclusion Criteria
- •Age \>= 20 years
- •Subjects with stable medication (\> 3 months) diagnosed as hypertension
- •Subjects have been thoroughly informed about this registry and signed an Informed Consent Form.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Distribution rate based on the home BP of the patients.
Time Frame: 7 days or more blood pressure measurement
Distribution rate based on the home BP of the patients who are defined as: * Masked morning hypertension * White-coat hypertension * Poorly controlled hypertension * Well controlled hypertension